L-theanine

N/A

Report date: 2026/05/09 20:00:18

Base Information

Drug NameL-theanine
Drug Alias NameN5-ethyl-L-glutamineL-茶氨酸谷氨酰乙胺
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionGlutamate [NMDA] receptor agonistsGABA receptors agonists
TargetsGlutamate [NMDA] receptorGABA receptors
Therapy Area/IndicationsSolid tumoursMental DisordersHematologic Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited States Minor Outlying Islands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesButler Hospital
China Registration ClassN/A

Develop Information

Active CompaniesButler HospitalNational Cancer Institute
Inactive CompaniesN/A
Active IndicationsSolid tumoursMental DisordersHematologic Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A